- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01045759
Point of Care Ultrasound (US) Versus Detailed Radiology US for Deep Vein Thrombosis (DVT)
September 29, 2016 updated by: University of Missouri-Columbia
Intensivist Performed Limited B Mode Compression Ultrasound for Diagnosis of Deep Vein Thrombosis in the Intensive Care Unit
We propose an observational study to assess the ability of intensivists to evaluate for deep vein thrombosis using 2 point compression ultrasonography.
Study Overview
Status
Terminated
Conditions
Detailed Description
Deep vein thrombosis is a common problem in the intensive care unit and diagnosis is often delayed due to limited availability of a formal duplex ultrasound.
Physician performed 2 point compression ultrasonography has been shown to have reasonable accuracy when performed in the emergency department and outpatient setting, but has not been studied on patients in the intensive care unit.
We propose an observational study to assess the ability of intensivists to evaluate for deep vein thrombosis using 2 point compression ultrasonography.
Study Type
Observational
Enrollment (Actual)
150
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Missouri
-
Columbia, Missouri, United States, 65212
- University of Missouri Healthcare
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
The study population will consist of adult patients admitted to the intensive care units at University hospital who have a duplex ultrasound of the lower extremities for detection of deep vein thrombosis ordered by the primary team.
Description
Inclusion Criteria:
- Male and female adults at least 18 years of age
- Duplex ultrasonography ordered by treating team
- Admission to the Medical, Cardiac, Burn, or Surgical intensive care units
Exclusion Criteria:
- Patients less than 18 years of age
- Patients with a known current DVT
- patients on whom the exam cannot be performed (above the knee amputation, severe cellulitis of groin or popliteal fossa, hip or knee fracture)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The agreement between physician performed ultrasound and formal duplex ultrasonography for detection of proximal deep vein thrombosis.
Time Frame: 48 hours window from detailed US
|
48 hours window from detailed US
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Subgroup analysis: location of thrombus (proximal or distal)
Time Frame: 48 hours window from detailed US
|
48 hours window from detailed US
|
Subgroup analysis: number of days in the hospital prior to exam
Time Frame: 48 hours window from detailed US
|
48 hours window from detailed US
|
Subgroup analysis: body mass index (BMI)
Time Frame: 48 hours window from detailed US
|
48 hours window from detailed US
|
Subgroup analysis: weight gain from admission to the time of the exam
Time Frame: 48 hours window from detailed US
|
48 hours window from detailed US
|
Subgroup analysis: training level of examiner
Time Frame: 48 hours window from detailed US
|
48 hours window from detailed US
|
Subgroup analysis: difficulty of exam
Time Frame: 48 hours window from detailed US
|
48 hours window from detailed US
|
Subgroup analysis: specific examiner
Time Frame: 48 hours window from detailed US
|
48 hours window from detailed US
|
Subgroup analysis: presence or absence of calf vein thrombosis
Time Frame: at study conclusion
|
at study conclusion
|
Subgroup analysis: presence or absence of pulmonary embolism
Time Frame: at study conclusion
|
at study conclusion
|
Subgroup analysis: DVT location
Time Frame: at study conclusion
|
at study conclusion
|
Subgroup analysis: calf vein thrombosis
Time Frame: at study conclusion
|
at study conclusion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Casey Stahlheber, MD, University of Missouri-Columbia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2009
Primary Completion (Actual)
May 1, 2015
Study Completion (Actual)
May 1, 2015
Study Registration Dates
First Submitted
January 7, 2010
First Submitted That Met QC Criteria
January 7, 2010
First Posted (Estimate)
January 11, 2010
Study Record Updates
Last Update Posted (Estimate)
September 30, 2016
Last Update Submitted That Met QC Criteria
September 29, 2016
Last Verified
September 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1143800
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on DEEP VEIN THROMBOSIS
-
University of OklahomaPfizerCompleted
-
University Medical Center GroningenCompletedSuspected Upper Extremity Deep Vein ThrombosisAustria, Netherlands, Italy, Belgium, Switzerland, Germany, United States
-
National Taiwan University HospitalUnknownUpper Extremity Deep Vein Thrombosis, SecondaryTaiwan
-
Vetex Medical Ltd.CompletedDeep Vein Thrombosis LegIreland, Germany, Bulgaria, United Kingdom
-
MinaPharm PharmaceuticalsRecruitingProphylaxis of Deep Vein ThrombosisEgypt
-
UPECLIN HC FM Botucatu UnespCompletedProphylaxis of Deep Vein ThrombosisBrazil
-
McMaster UniversityCanadian Institutes of Health Research (CIHR)CompletedSuspected Deep Vein ThrombosisCanada
-
Diakron PharmaceuticalsCompleted
-
BayerRecruitingThrombolysis | Symptomatic Proximal Deep Vein ThrombosisBelgium, France, Italy, Netherlands, Canada, Germany
-
Oregon Health and Science UniversityTerminated